Charlottesville, VA2 Active Studies

Parkinsons Disease Clinical Trials in Charlottesville, VA

Find 2 actively recruiting parkinsons disease clinical trials in Charlottesville, VA. Connect with local research sites and explore new treatment options.

2
Active Trials
1
Sponsors
1,500
Enrolling

Recruiting Parkinsons Disease Studies in Charlottesville

About Parkinsons Disease Clinical Trials in Charlottesville

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 2 parkinsons disease clinical trials recruiting participants in Charlottesville, VA. These studies are seeking a combined 1,500 participants. Research is being sponsored by University of Virginia. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Charlottesville — FAQ

Are there parkinsons disease clinical trials in Charlottesville?

Yes, there are 2 parkinsons disease clinical trials currently recruiting in Charlottesville, VA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Charlottesville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Charlottesville research site will contact you about next steps.

Are clinical trials in Charlottesville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Charlottesville studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 2 active trials in Charlottesville are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated July 18, 2026 from ClinicalTrials.gov